Structural Impacts of Drug-Resistance Mutations Appearing in HIV-2 Protease
The use of antiretroviral drugs is accompanied by the emergence of HIV-2 resistances. Thus, it is important to elucidate the mechanisms of resistance to antiretroviral drugs. Here, we propose a structural analysis of 31 drug-resistant mutants of HIV-2 protease (PR2) that is an important target again...
Main Authors: | Pierre Laville, Michel Petitjean, Leslie Regad |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/3/611 |
Similar Items
-
Exploration of the Structural Asymmetry Induced by the Intrinsic Flexibility of HIV-2 Protease
by: Anne Badel, et al.
Published: (2022-02-01) -
Spontaneous Mutations in HIV-1 Gag, Protease, RT p66 in the First Replication Cycle and How They Appear: Insights from an In Vitro Assay on Mutation Rates and Types
by: Joshua Yi Yeo, et al.
Published: (2020-12-01) -
HIV Protease: Historical Perspective and Current Research
by: Irene T. Weber, et al.
Published: (2021-05-01) -
Spectrum of Atazanavir-Selected Protease Inhibitor-Resistance Mutations
by: Soo-Yon Rhee, et al.
Published: (2022-05-01) -
Drug Reprofiling to Identify Potential HIV-1 Protease Inhibitors
by: Sunday N. Okafor, et al.
Published: (2023-08-01)